Navigation Links
Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack
Date:6/9/2009

atal myocardial infarction and stroke in patients with type 2 diabetes. The approach in this selected high-risk patient population will be unique as no drug has been demonstrated to reduce cardiovascular risk in type 2 diabetes patients following an ACS event.

Professor Robert Henry, SYNCHRONY Clinical Investigator and Chief VA Endocrinology & Metabolism and Professor of Medicine in Residence at the University of California at San Diego, commented: "The favorable balance in the safety and efficacy profile of aleglitazar seen in the SYNCHRONY study represents encouraging short-term clinical data for this agent and provides good evidence to enter Phase III investigation."

With the decision to move into Phase III, aleglitazar is Roche's third Phase III clinical trial program in the area of metabolism. The new Phase III study is a cardiovascular outcomes trial designed to assess the potential of once-daily 150 micrograms aleglitazar to reduce cardiovascular mortality, non-fatal myocardial infarction and stroke in type 2 diabetes patients with a recent ACS.

About the SYNCHRONY Study

SYNCHRONY was a multicenter, randomized, double-blind, placebo-controlled dose ranging study among 332 type 2 diabetes patients (either drug-naive or pre-treated with less than or equal to 2 oral agents). Designed to determine the glucose-lowering and lipid-modifying effects, and safety profile of aleglitazar, the study confirmed the favorable safety and efficacy profile of the once daily 150 microgram aleglitazar dose and supported commencement of the Phase III clinical investigation.

Patients underwent a single-blind 4- to 5-week placebo run-in period, then were randomized to receive 16 weeks treatment with either aleglitazar at one of four once daily doses (50, 150, 300 or 600 micrograms), placebo or 45 mg pioglitazone.

The primary endpoint of dose-dependent reduction
'/>"/>

SOURCE Roche
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier
2. moksha8 Expands Alliance With Roche to Commercialize $200 Million of Products in Brazil and Mexico
3. Roches Pierson Honored as 2009 HBA Rising Star
4. Corporate Pandemic Preparedness Experts from Roche & PSEG to Advise Savvy Business Leaders May 15
5. Roche Women Honored as 2009 TWIN Awardees
6. Rochester Medical Reports Second Quarter Results
7. Sanofi-Aventis and Roche/Chugais Drugs Will Dominate the Indian Colorectal Cancer Drug Market Through 2013
8. Roche Announces New Co-pay Program in Pennsylvania that Makes It Easier for Patients with Diabetes to Receive Savings on ACCU-CHEK(R) Blood Glucose Test Strips
9. Roche Announces New Co-pay Program in Florida that Makes It Easier for Patients with Diabetes to Receive Savings on ACCU-CHEK(R) Blood Glucose Test Strips
10. Roche Announces New Co-Pay Program in California That Makes it Easier for Patients With Diabetes to Receive Savings on ACCU-CHEK(R) Blood Glucose Test Strips
11. Rochester Medical Announces Second Quarter 2009 Earnings Conference Call April 30, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2014)... Huntington, New York (PRWEB) September 21, 2014 ... release of their Risk Management Portal designed for ... applications with the intent to support effective risk ... is scheduled to go live coinciding with Waldorf’s ... September 21-24, 2014. , These applications were developed ...
(Date:9/21/2014)... PA (PRWEB) September 21, 2014 "I ... boost without having to consume sugary, foul-tasting energy drinks," ... did not always just want to drink plain, old ... alternative energy booster." , He developed ENERG CHEWING GUM ... assist with weight loss. The formula contains nutritious vitamins, ...
(Date:9/21/2014)... cancer cells metastasize? Think of Sparta. , Ancient Greek ... them for the demands of battle on distant fields. ... according to a new study revealing previously unknown differences ... original tumor site, and those that travel to other ... to metastasize is the primary cause of cancer-related death, ...
(Date:9/21/2014)... September 21, 2014 "I want to ... and back but haven’t the money for chiropractors," said ... to have such a product for myself." , The ... to stretch the thigh muscles and align the spine ... as relieves discomfort of pinched nerves. Compact and easy ...
(Date:9/21/2014)... NY (PRWEB) September 21, 2014 ... develops, implements and supports electronic medical records (EMR) ... benefited from federal healthcare legislation during the past ... do so during the five years to 2019. ... Clinical Health Act established Medicare and Medicaid incentives ...
Breaking Medicine News(10 mins):Health News:Waldorf Risk Solutions Releases New Risk Management Portal 2Health News:Cancer cells adapt energy needs to spread illness to other organs 2Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 4
... in Mumbai suffers from backache, caused mainly by the poor ... out by Health India, a New Delhi-based non-profit group, the ... Delhi and 77 percent in Mumbai who use public transport ... ,"Bad roads, overcrowded public transport systems, poor quality of ...
... On the eve of the World AIDS Day (Dec 1), ... to 20,000 HIV infected children, Health Minister Anbumani Ramadoss said ... launching a scheme to provide free ARV treatment for children ... for the paediatric drugs and three to four pharmaceutical companies ...
... of Secondary Education (CBSE) has taken following measures to ... a joyful //experience:- ,(i) Abolition of homework for ... ,(ii) Interesting and meaningful alternative activities to replace the ... ,(iii) Continuous and Comprehensive Evaluation from class ...
... device's track record in the United Kingdom concluded that ... the technology's use at least// for now. The review ... Assessment, the international journal series of the Health Technology ... Research in the United Kingdom. ,An implantable ...
... The Minister of Tourism and Culture Smt. Ambika Soni ... promoting India as a Global Health Care Destination. ... foreign tourist to the country Ministry of Tourism in ... the following measures to promote Medial Tourism: ,i) ...
... a heart attack indicates future heart problems, according to ... edition of the// Journal of the American College of ... of depression after having a heart attack are at ... to undergo new depression-related screening protocols and treatment strategies. ...
Cached Medicine News:Health News:Public Transport Causing Backaches in Delhi, Mumbai 2Health News:Free HIV Treatment to Be Launched for Children 2Health News:Review Urges Restricted Use Of Devices To Keep Heart Patients Alive 2Health News:Review Urges Restricted Use Of Devices To Keep Heart Patients Alive 3Health News:Depression After Heart Attack Means More Heart Problems 2Health News:Depression After Heart Attack Means More Heart Problems 3
(Date:9/19/2014)... , Sept. 19, 2014 Harwood Feffer LLP ... board of directors of PDL BioPharma, Inc. ("PDL" or ... the board has breached its fiduciary duties to shareholders ... September 16, 2014, the Company disclosed: "On September 11, ... accounting firm, Ernst & Young LLP ("EY"), that it ...
(Date:9/19/2014)... 19, 2014 "Copay coupons," a ... of brand drugs among patients with prescription drug coverage, may ... a new report  from the Department of ... General (OIG). Federal anti-kickback laws prohibit suppliers from ... subsidized by the federal government. ...
(Date:9/19/2014)... Sept. 19, 2014 Today, iHealth Lab Inc. announced ... Ventures, Ltd. for its first institutional round of funding. ... iHealth,s global reach, accelerate growth and innovation, and invest ... the investment, Xiaomi Ventures will join iHealth,s board of ... infrastructure and ecommerce. "We are very pleased ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc. 2PCMA: New OIG Report Cites Drug Manufacturer "Copay Coupon" Use in Medicare Part D 2iHealth Raises $25 Million to Fuel Growth and Global Market Share 2
... , , GREENSBORO, N.C., Dec. 23 ... four users who allege kidney damage due to the use ... in preparation for a colonoscopy. (Holshouser et al v. ... are against two Morrisville, N.C., pharmaceutical companies, Salix Pharmaceuticals, Ltd., ...
... , , Accelerated approval ... Dec. 23 The U.S. Food and Drug Administration today ... ages 65 years and older to prevent disease caused by ... http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) , People in this age group ...
Cached Medicine Technology:Suits Commenced Against Maker of Prescription Cleansing Drug 2FDA Approves a High Dose Seasonal Influenza Vaccine Specifically Intended for People Ages 65 and Older 2FDA Approves a High Dose Seasonal Influenza Vaccine Specifically Intended for People Ages 65 and Older 3
2.5% Soytone, 4.8% Yeast Extract, 0.025% Magnesium Sulfate, 130mM Calcium Chloride....
12% Tryptone, 24% Yeast Extract, 4.0% Glycerol. Supplied with 1 liter of 10x phosphate buffer (0190-1L)....
1.0% Casein digest (NZ amine), 0.5% Sodium Chloride, 0.5% Yeast Extract, 1.0% bacto casamino acids, 0.2% Mag. Sulfate....
S.O.C. Medium...
Medicine Products: